---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-253435"
form_type: "8-K"
ticker: "TYRA"
cik: "0001863127"
company_name: "Tyra Biosciences, Inc."
filed_at: "2026-06-02T20:01:13+00:00"
generated_at: "2026-06-02T20:02:40.620134+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Tyra Biosciences elects three Class II directors, ratifies Ernst & Young as auditor at 2026 annual meeting

## Summary
- Habib J. Dable, Susan Moran, and Robert More elected Class II directors for three-year terms.
- Robert More received 41,013,686 for and 3,705,719 withheld (8.3% withheld); Dable and Moran had under 1.1% withheld.
- Ernst & Young ratification: 53,092,820 for, 1,316 against, 3,246 abstentions; no broker non-votes on this proposal.
- Broker non-votes on director election: 8,377,977 for each director.

## SEC filing metadata
- accession: 0001193125-26-253435
- form_type: 8-K
- ticker: TYRA
- cik: 0001863127
- company_name: Tyra Biosciences, Inc.
- filed_at: 2026-06-02T20:01:13+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1863127/000119312526253435/0001193125-26-253435-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1863127/000119312526253435/d33725d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-253435
- JSON: https://secwatch.observer/filing/0001193125-26-253435.json
- Plain text: https://secwatch.observer/filing/0001193125-26-253435.txt

## Key facts
- Shareholder Votes
  Tyra Biosciences, Inc. shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-05-28 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-05-28
  source text: 2. The ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The appointment was ratified by the votes indicated: For Against Abstain Broker Non-Votes 53,092,820 1,316 3,246 –
  evidence_url: https://www.sec.gov/Archives/edgar/data/1863127/000119312526253435/0001193125-26-253435-index.htm
- Shareholder Votes
  Tyra Biosciences, Inc. shareholders approved Election of three Class II directors to serve for a three-year term expiring at the 2029 Annual Meeting of Stockholders. at the 2026-05-28 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-05-28
  source text: 1. The election of three directors to serve as Class II directors for a three-year term to expire at the 2029 Annual Meeting of Stockholders. The following three Class II directors were elected by the votes indicated: For Withheld Broker Non-Votes Habib J. Dable 44,242,803 476,602 8,377,977 Susan Moran, M.D., M.S.C.E. 44,529,688 189,717 8,377,977 Robert More 41,013,686 3,705,719 8,377,977
  evidence_url: https://www.sec.gov/Archives/edgar/data/1863127/000119312526253435/0001193125-26-253435-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.